. Author manuscript; available in PMC: 2015 Apr 1.

Published in final edited form as: Am J Hematol. 2014 Mar 7;89(4):395–398. doi: 10.1002/ajh.23655

Table 2.

Comparison of outcomes of allogeneic hematopoietic stem cell transplantation and salvage chemotherapy of patients with acute myeloid leukemia

Parameter	AHSCT group, N=28	Salvage chemotherapy group, N=149	P-value
CR/CRp (%)	23 (82)	16 (11)	<0.001
Median OS (months, range)	15.7 (1.1–114)	2.9 (0.1–128)	<0.001
3-year OS rate (%)	39	2	<0.001
Median DFS (months, range)	14.8 (0.9–122)	4.9 (0.6–126)	0.076
3-year DFS (%)	35	13	0.076

AHSCT= Allogeneic hematopoietic stem cell transplantation; CR= complete remission; CRp= complete remission with incomplete platelet recovery; OS= overall survival; DFS= disease-free survival